Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated to v3.5.2. Related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed, replacing the previous revision tag v3.5.0.SummaryDifference0.2%

- Check14 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page's related topics section.SummaryDifference0.1%

- Check21 days agoChange DetectedDeleted the 'Multiple Myeloma' condition entry and the 'MedlinePlus Genetics' related topic section from the page.SummaryDifference0.1%

- Check35 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study content or layout.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page.SummaryDifference0.1%

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.